Candel Therapeutics, Inc. - Common Stock (NQ:CADL)
Price and Volume
Detailed Quote| Volume | 739,826 |
| Open | 5.630 |
| Bid (Size) | 5.200 (100) |
| Ask (Size) | 5.450 (300) |
| Prev. Close | 5.710 |
| Today's Range | 5.240 - 5.670 |
| 52wk Range | 4.250 - 13.68 |
| Shares Outstanding | 28,919,810 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Candel Therapeutics to Host Virtual R&D Event on December 5, 2025
November 17, 2025
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
October 14, 2025
Candel Therapeutics to Present at the SITC 2025 Annual Meeting
October 03, 2025
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
September 03, 2025
Candel Reports 88 Percent Q2 Loss Drop ↗
August 14, 2025
Frequently Asked Questions
Is Candel Therapeutics, Inc. - Common Stock publicly traded?
Yes, Candel Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Candel Therapeutics, Inc. - Common Stock trade on?
Candel Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Candel Therapeutics, Inc. - Common Stock?
The ticker symbol for Candel Therapeutics, Inc. - Common Stock is CADL on the Nasdaq Stock Market
What is the current price of Candel Therapeutics, Inc. - Common Stock?
The current price of Candel Therapeutics, Inc. - Common Stock is 5.290
When was Candel Therapeutics, Inc. - Common Stock last traded?
The last trade of Candel Therapeutics, Inc. - Common Stock was at 02/05/26 04:00 PM ET
What is the market capitalization of Candel Therapeutics, Inc. - Common Stock?
The market capitalization of Candel Therapeutics, Inc. - Common Stock is 152.99M
How many shares of Candel Therapeutics, Inc. - Common Stock are outstanding?
Candel Therapeutics, Inc. - Common Stock has 153M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube